// // It is highly recommended to set this option, even though it's not required. // defaults to undefined. //appElement: "#page-container", // Optional. You can customize the name of the cookie that Orejime uses for storing // user consent decisions. // defaults to "orejime". cookieName: "diadao_cookies", // Optional. You can set a custom expiration time for the Orejime cookie, in days. // defaults to 365. cookieExpiresAfterDays: 365, // You must provide a link to your privacy policy page privacyPolicy: JSON.parse(Config.orejimePrivacyPolicyPage), // You must provide a link to your cookies policy page cookiePolicy: JSON.parse(Config.orejimeCookiesPage), // Optional. Applications configured below will be ON by default if default=true. // defaults to true default: true, // Optional. If "mustConsent" is set to true, Orejime will directly display the consent // manager modal and not allow the user to close it before having actively // consented or declined the use of third-party apps. // defaults to false mustConsent: false, // Optional. If "implicitConsent" is set to true, Orejime will automatically accept // cookies if the user continues his navigation on the website after the // first page. If you enable this, you must warn the user // of this behavior in the notice window. You can do that easily by overriding // translation strings (see below). // defaults to false implicitConsent: false, // Optional. You can define the UI language directly here. If undefined, Orejime will // use the value given in the global "lang" variable, or fallback to the value // in the lang attribute, or fallback to "en". lang: Config.currentLang, // You can overwrite existing translations and add translations for your // app descriptions and purposes. See `src/translations.yml` for a full // list of translations that can be overwritten // translations: Config.texts.orejime, // If you want to use custom text for your project translations: {}, // The list of third-party apps that Orejime will manage for you. // The apps will appear in the modal in the same order as defined here. // appsList: ["analytics", "big_calendar", "orejime", "offerhighlight"], appsList: JSON.parse(Config.orejimeAppsList), apps: [] }

见所未见,
拯救生命

创新,拯救生命

支持更有效的临床决策

日复一日,我们扩展拯救生命的边界

为什么选择 Intrasense 解决方案?

关注最重要的事情

利用我们的人工智能增强型用户友好软件解决方案,更快地进行解读,更有效地进行监控

运用先进的全融合的可视化工具

创建具有丰富细节的、更有效的人工智能流程
申请试用

让人工智能可及

当医学影像领域都在谈论人工智能时,我们的目标是让人工智能触手可及!
我们的技术让放射科医生和临床医生通过将人工智能系统构建到他们的工作流程中,专注于医疗质量,所有这些都关注于临床需求。
我们的人工智能驱动的临床应用程序是按照最高的临床标准构建的。"

创新的协作解决方案完全集成到任何医疗保健信息系统中

20 年创新历程
全球 1,200 家客户
70 名员工致力于拯救生命
170 篇科学著作和多项技术专利

新闻

Intrasense announces CE certification of Liflow® to the new European regulation (MDR)

29 4 月 2024
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense announces the appointment of Jérôme Thiebaud as Chief Business Officer

24 4 月 2024
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Presentation of annual results for 2023 and ambitions for 2024

22 4 月 2024
Intrasense presents its 2023 annual results.Discover in this webinar the progress of Intrasense's medical imaging solutions, its 2024 objectives and ambitions.
发现更多

Liflow®: an innovative AI-enhanced solution to optimize oncology follow-up

16 4 月 2024
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense and Guerbet announce CE certification of Myrian 2.12, enhanced with Guerbet's prostate AI

8 4 月 2024
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多

Intrasense presents its innovations at the European Congress of Radiology (ECR) 2024

26 2 月 2024
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense announces the certification of Myrian® to the new European regulation (MDR)

21 2 月 2024
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense announces annual revenue for 2023

8 2 月 2024
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多

Intrasense and the ICM sign a partnership to optimize a new solution dedicated to oncology

6 2 月 2023
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多

Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions

11 1 月 2023
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多

Presentation of the half-yearly financial results 2022

21 10 月 2022
To coincide with the publication of its half-year results for 2022, Intrasense will provide an update on its latest developments.
发现更多

2022-half-year results: continued growth momentum

12 10 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense signs a historic contract with Brazilian medical technology leader MV

11 10 月 2022
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多

Intrasense attends the 70th edition of the "Journées Francophones de Radiologie" 

29 9 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense signs a strategic partnership with Nurea

1 6 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Intrasense launches its AI Hub in partnership with Milvue

17 5 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Availability of the 2021 annual financial report

20 4 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

TeleDiag chooses Intrasense by signing a commercial contract for teleradiology

5 4 月 2022
Intrasense (FR0011179886 - ALINS), specialist in medica […]
发现更多

Presentation of 2021 annual results and 2022 ambitions

14 3 月 2022
On the occasion of the publication of its 2021 annual results, Intrasense will provide an update on its latest developments.
发现更多

Intrasense 2021 results: record business growth

10 3 月 2022
Intrasense (FR0011179886 - ALINS), a specialist in medi […]
发现更多
1 2 3 5